Cetera Investment Advisers

Position in GMAB — Genmab A/S

CIK 1666741 SCHAUMBURG, IL

Position in GMAB

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$2,184,498

-$400,361 QoQ

Shares Held

81,420

-3.0% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Cetera Investment Advisers holds $158,169,500 across 104 Biotechnology names. GMAB ranks #18 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	72,633	$32,433,539
2	REGN	Regeneron Pharmaceuticals, Inc.	16,006	$12,366,875
3	ALNY	Alnylam Pharmaceuticals, Inc.	23,173	$7,667,250
4	EXEL	Exelixis, Inc.	169,881	$7,286,196
5	IBRX	ImmunityBio, Inc.	946,709	$7,261,258
6	OCUL	Ocular Therapeutix, Inc	764,615	$6,476,289
7	VKTX	Viking Therapeutics, Inc.	189,028	$6,150,971
8	INSM	INSMED Inc	34,356	$5,617,893

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,184,498	81,420	-3.0%	Shares	Sole	2026-05-13
2025-12-31	$2,584,859	83,924	+13.4%	Shares	Sole	2026-02-17
2025-09-30	$2,269,426	73,995	+543.0%	Shares	Sole	2025-11-14
2024-09-30	$280,565	11,508	+30.4%	Shares	Sole	2024-11-13
2024-06-30	$221,721	8,823	-20.3%	Shares	Sole	2024-08-22
2024-03-31	$331,193	11,073	+43.9%	Shares	Sole	2024-05-24
2023-09-30	$271,402	7,695	-9.5%	Shares	Sole	2023-11-14
2023-06-30	$323,085	8,500	-21.4%	Shares	Sole	2023-08-10
2023-03-31	$408,336	10,814	-36.4%	Shares	Sole	2023-05-15
2022-12-31	$721,095	17,015	+35.8%	Shares	Sole	2023-02-14
2022-09-30	$402,685	12,533	+68.0%	Shares	Sole	2022-11-14
2021-12-31	$295,196	7,462	+9.1%	Shares	Sole	2022-02-14
2021-09-30	$298,995	6,842	+36.1%	Shares	Sole	2021-11-16
2021-06-30	$205,252	5,027	—	Shares	Sole	2021-08-13
No filing history on record for this holder in this stock.